CNTA

Centessa Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↓ 0/10
  • Value↑ 6/10
Centessa Pharmaceuticals sales and earnings growth
CNTA Growth
Low
  • Revenue Y/Y↓ -100.00%
  • EPS Y/Y↓ 4.79%
  • FCF Y/Y↓ -29.08%
Centessa Pharmaceuticals gross and profit margin trends
CNTA Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -62.21%
Centessa Pharmaceuticals net debt vs free cash flow
CNTA Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 0.3
  • Interest coverage↓ -21.0

Centessa Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks